🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the pharmacokinetic effects and saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-28
Trial ID
NCT07792408
This is a study designed to ascertain the effect of PF-04447943 on QT inter...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-06-29
Trial ID
NCT02785770
Treatments Being Tested
The primary objective of the study is: • To assess the effects of a single...
Status
Completed
Location
Fortrea Clinical Research Unit Limited - Leeds
Start Date
2024-09-12
Trial ID
NCT06411860
Treatments Being Tested
This was a single-center, multiple-dose, randomized, double-blind, placebo-...
Status
Completed
Location
PRA International Clinical Pharmacology Center (EDS US Clinic)
Start Date
2019-02-07
Trial ID
NCT03808298
Treatments Being Tested
The purpose of this study is to assess the effect of canagliflozin (JNJ-284...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT01787357
Treatments Being Tested
To determine if a single subcutaneous (SC) administration of TTX at various...
Status
Completed
Location
Celerion
Start Date
2018-02-07
Trial ID
NCT04083833
Treatments Being Tested
In this study, researchers want to find whether the study drug BAY1817080 h...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2020-06-18
Trial ID
NCT04423744
Treatments Being Tested
This is a randomized, double-blind (with respect to Tebipenem pivoxil hydro...
Status
Completed
Location
Celerion
Start Date
2020-01-19
Trial ID
NCT04238195
Randomized, single-dose, double-blind, placebo and active controlled, four-...
Status
Completed
Location
Celerion
Start Date
2012-11
Trial ID
NCT01860703
Treatments Being Tested
This is a phase 2B, open label study, that will compare the safety and effi...
Status
Unknown
Location
TASK Applied Sciences Clinical Research Centre
Start Date
2023-09-21
Trial ID
NCT05926466
Treatments Being Tested